0
     

Report Added
Report already added
Analgesics in Canada

Analgesics in Canada

In 2022, analgesics is anticipated to record positive retail value sales growth, but this growth will be driven largely by inflation-based price increases, with category volume sales dropping by 1%. This is reflective of the way in which Canadians used analgesics during the COVID-19 pandemic for a wide variety of purposes, including core pain relief, symptomatic relief (particularly among elderly Canadians) and pain management while waiting for nonurgent, elective surgery, which was postponed as...

Euromonitor International's Analgesics in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Analgesics in Canada

List Of Contents And Tables

ANALGESICS IN CANADA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Inflation-based price increases drive analgesics retail value sales growth in 2022
Topical analgesics benefits from the resumption of physical activity
Multinationals leverage extensive distribution and product ranges to lead sales
PROSPECTS AND OPPORTUNITIES
An ageing population will continue to bolster sales of analgesics in Canada
Consumers pay attention to companies’ stance on social issues
CBD topical analgesics are set to perform well in the coming years
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2017-2022
Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN CANADA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Report Title: Analgesics in Canada


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW